Becki Lee

@beckilee.bsky.social

Melanoma oncologist at The Christie. Wellcome early career fellow at University of Manchester, The Francis Crick and UCL. Interested in tumour local and systemic immune changes, metastasis, ctdna and cancer evolution. Music, art, politics, hiking.

OpenSAFELY is open from today! Huge thanks to all who supported this vast collaboration: whole population GP data; in a productive platform; innovative privacy protections; unprecedented support from professions, privacy campaigners; &c Now it's over to users! www.bennett.ox.ac.uk/blog/2026/02...

OpenSAFELY news: you can apply to do non-COVID research, from today! | Bennett Institute for Applied Data Science

We are delighted to announce that - from today - you can submit applications to the OpenSAFELY service for non-COVID-19 studies.

bennett.ox.ac.uk

⏰ Calling all melanoma enthusiasts! The abstract submission deadline for the inaugural “Lab to Life: Innovations in Melanoma Research Conference UK 2026” has been extended to 19 December 2025! Happening 12-13 March 2026 at The Midland Hotel, Manchester. Submit your abstract and register here:

Home

Lab to Life: Innovations in Melanoma is a UK conference in Manchester on cutting-edge melanoma research, translational science and advances in treatments.

sites.manchester.ac.uk

NEW: Nature trained AI to predict which NIH grants from 2014 would have been cut if the Trump admin had its way back then — and what science would have been lost to history. "The results show the damage that cuts in funding can do to research, and the unpredictable nature of the research process."

Nature@nature.com · 10mo ago

We used machine-learning tools in an attempt to recreate the method for cutting funding, and then applied it to past US NIH grants to reveal the broad-reaching consequences go.nature.com/4pBArFH

v1.108 is rolling out today 🚚 Now live, at long last: Bookmarks, aka Saved Posts. For all those posts you'll definitely plan to come back to! Update the app and give it a try. The button is right down there 👇

I’m happy to share our latest work on tumour necrosis! During my time in the @megeblad.bsky.social lab, we found that tumour necrosis is not a passive phenomenon secondary to tumour growth, but an active phenomenon driven by neutrophils and NETs! Thread below: (1/13) www.nature.com/articles/s41...

Neutrophils drive vascular occlusion, tumour necrosis and metastasis - Nature

Neutrophils actively induce tumour necrosis, driving vascular occlusion, pleomorphic necrosis and metastasis.

nature.com

Absolutely loving this course - fantastic discussions between all and the delegates and faculty. So many exciting Q's coming out of this!

Trevor Graham@trevorgraham.bsky.social · last yr.

Now medical oncologist and clinician scientist @beckilee.bsky.social leading the first clinical session. Discussing how to bring evolutionary and ecological ideas into molecular tumour boards, and how to design evo clinical trials for better treatment regimens. #EBEcancer25 @eventswcs.bsky.social